Indefinite Delivery Contract SPE2DU25D9536
- Not listed
- The federal contract IDV award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is for an Indefinite Delivery Contract (IDC) valued at up to $499,999,999 through November 2026. This single-award IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through November 2026, covers a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables...
- The federal contract IDV awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is an Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The purpose of this IDC is to provide the DLA with a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter...
- The federal contract IDV award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, covers a wide range of pharmaceutical products and medical supplies to support the medical needs of Department of Defense (DoD) healthcare facilities and the U.S. Coast Guard. The single-award Indefinite Delivery Contract (IDC), valued at $499,999,999 and valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic...
- The federal contract IDV award is for an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, provides a vehicle for the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This...
- The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government customers. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications,...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply...
The federal contract IDV award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 and valid through November 2026. The contract enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The original solicitation, expected to be issued in March 2024, is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple regional contracts for pharmaceutical support to various Department of Defense (DoD) customers, the United States Coast Guard, and other government agencies. The unrestricted, fully competitive acquisition will be awarded on a lowest price technically acceptable (LPTA) basis, with the potential use of reverse auctions to obtain the best distribution fees. The total estimated value for all regions and option periods is $30.3 billion.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/7/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmaceutical Prime Vendor Global GEN V Presolicitation | SPE2DX-24-R-0001 | Defense Logistics Agency Troop Support Medical | Pre-Solicitation 1/5 | 2/1/24, 3:44 PM | |
Pharmaceutical Prime Vendor Global GEN V Solicitation | SPE2DX-24-R-0001_SOLICITATION | Defense Logistics Agency Troop Support Medical | Solicitation 2/5 | 3/13/24, 11:08 AM | |
PPVG GEN V Award | SPE2DX-25-D-1000 | Defense Logistics Agency Troop Support Medical | Award Notice 3/5 | 3/7/25, 10:09 AM | |
PPVG GEN V AWARD SPE2DX25D9000 | SPE2DX25D9000 | Defense Logistics Agency Troop Support Medical | Award Notice 4/5 | 3/7/25, 10:14 AM | |
PPVG GEN V AWARD SPE2DX25D8000 | SPE2DX25D8000 | Defense Logistics Agency Troop Support Medical | Award Notice 5/5 | 3/7/25, 10:18 AM |